Post-earnings recap
Reported
Wed, May 2, 2018
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Bio-Techne Corp reported a better-than-expected EPS, indicating solid performance on that front. However, the stock fell by 2.66% in reaction to the lack of revenue details and guidance. Investors may be concerned about the absence of specific future projections, which could impact confidence going forward.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.21 | N/A | +4.11% |
| Revenue | N/A | N/A | N/A |
Overall, management conveyed a sense of cautious optimism about future prospects. They emphasized the need for ongoing innovation and strategic focus.
Management highlighted the importance of continued innovation in their product offerings.
They expressed confidence in their long-term growth strategy despite current market challenges.